menu
    • menu

    Company profile for Lobe Sciences

    NEW Drugs in Dev: 3
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lobe Sciences is a life sciences company focused on psychedelic medicines. The company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness. The company is also developing transformative medicines to treat Orphan diseases to benefit patients of all ag...
    Lobe Sciences is a life sciences company focused on psychedelic medicines. The company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness. The company is also developing transformative medicines to treat Orphan diseases to benefit patients of all ages.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lobe SciencesCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Suite 1400-1199 West Hastings Street Vancouver BC V6E3T2
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lobesciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lobe-sciences/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lobe Sciences at Jefferies, Leerink Conferences in Miami
    Lobe Sciences at Jefferies, Leerink Conferences in Miami

    05 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-05/lobe-sciences-ltd-announces-presence-in-miami-during-the-jefferies-and-leerink-healthcare-conferenc

    PHARMIWEB
    05 Mar 2026
    Share Share
    Lobe Sciences Reports First Quarter 2026 Results And Highlights
    Lobe Sciences Reports First Quarter 2026 Results And Highlights

    03 Feb 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-reports-first-quarter-2026-results-and-highlights-1132910

    ACCESSWIRE
    03 Feb 2026
    Share Share
    Lobe Sciences Strengthens Strategy And Balance Sheet In FY2025
    Lobe Sciences Strengthens Strategy And Balance Sheet In FY2025

    08 Jan 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-reports-fy2025-with-a-stronger-balance-sheet-and-sharpened-strategy-1125488

    ACCESSWIRE
    08 Jan 2026
    Share Share
    Lobe Sciences Reports FY 2025 Results Post-Leadership Shift
    Lobe Sciences Reports FY 2025 Results Post-Leadership Shift

    06 Jan 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-reports-fiscal-2025-results-and-highlights-strategic-transformation-fol-1124316

    ACCESSWIRE
    06 Jan 2026
    Share Share
    Lobe Sciences Improves Balance Sheet
    Lobe Sciences Improves Balance Sheet

    09 Oct 2025

    // ACCESSWIRE BIO

    https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-improves-balance-sheet-1084862

    ACCESSWIRE BIO
    09 Oct 2025
    Share Share
    Lobe Sciences Secures $341,425 CAD in Private Placement
    Lobe Sciences Secures $341,425 CAD in Private Placement

    29 Jul 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/lobe-sciences-announces-341-425-cad-private-placement-for-general-corporate-purposes-1053925

    ACCESSWIRE
    29 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search